Bristol Myers Squibb Co. (BMY)
67.31
+0.30
(+0.45%)
USD |
NYSE |
Aug 24, 16:00
67.13
-0.18
(-0.27%)
After-Hours: 20:00
Bristol Myers Squibb EPS Diluted (Quarterly) : 1.620 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.620 |
| March 31, 2026 | 1.308 |
| December 31, 2025 | 0.5326 |
| September 30, 2025 | 1.079 |
| June 30, 2025 | 0.6428 |
| March 31, 2025 | 1.204 |
| December 31, 2024 | 0.0354 |
| September 30, 2024 | 0.5963 |
| June 30, 2024 | 0.828 |
| March 31, 2024 | -5.888 |
| December 31, 2023 | 0.8667 |
| September 30, 2023 | 0.9341 |
| June 30, 2023 | 0.9862 |
| March 31, 2023 | 1.070 |
| December 31, 2022 | 0.952 |
| September 30, 2022 | 0.7477 |
| June 30, 2022 | 0.6612 |
| March 31, 2022 | 0.5906 |
| December 31, 2021 | 1.069 |
| September 30, 2021 | 0.6893 |
| June 30, 2021 | 0.4685 |
| March 31, 2021 | 0.8923 |
| December 31, 2020 | -4.452 |
| September 30, 2020 | 0.8175 |
| June 30, 2020 | -0.0376 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3432 |
| December 31, 2019 | -0.5506 |
| September 30, 2019 | 0.828 |
| June 30, 2019 | 0.8748 |
| March 31, 2019 | 1.045 |
| December 31, 2018 | 0.7282 |
| September 30, 2018 | 1.162 |
| June 30, 2018 | 0.228 |
| March 31, 2018 | 0.9061 |
| December 31, 2017 | -1.424 |
| September 30, 2017 | 0.5137 |
| June 30, 2017 | 0.5552 |
| March 31, 2017 | 0.942 |
| December 31, 2016 | 0.5321 |
| September 30, 2016 | 0.7159 |
| June 30, 2016 | 0.6945 |
| March 31, 2016 | 0.7113 |
| December 31, 2015 | -0.0827 |
| September 30, 2015 | 0.4207 |
| June 30, 2015 | -0.078 |
| March 31, 2015 | 0.7076 |
| December 31, 2014 | 0.0078 |
| September 30, 2014 | 0.4317 |
| June 30, 2014 | 0.1995 |
| March 31, 2014 | 0.5624 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Merck & Co., Inc. | -0.5405 |
| Pfizer Inc. | -0.0435 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.316B |
| Revenue (Quarterly) | 12.98B |
| Total Expenses (Quarterly) | 9.665B |
| Enterprise Value | 170.89B |
| Gross Profit Margin (Quarterly) | 67.95% |
| Profit Margin (Quarterly) | 25.54% |
| Earnings Yield | 6.74% |
| Operating Earnings Yield | 11.57% |
| Normalized Earnings Yield | 9.125 |